Abstract P5-17-04: Long term hair loss in patients with early breast cancer receiving docetaxel chemotherapy

Background There is increasing recognition that a small number of patients receiving docetaxel-containing regimes for early breast cancer (EBC), experience permanent alopecia. However, there is little data to inform discussions with patients regarding this serious late side effect. The aim of this study was determine the incidence, the site, the extent, and duration of the hair loss. Methods A postal questionnaire was sent (in October 2013) to...